Xin‐Mei Cao

机构：Beijing VDJBio (China), Shanghai CASB Biotechnology (China)

发表论文 6 篇 · 总被引 81 次 · h-index 4

代表论文

• Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia (2007 · American Journal of Hematology · 被引 34)
• A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6 (2004 · Leukemia Research · 被引 29)
• Successful treatment of primary refractory anemia with a combination regimen of all-trans retinoic acid, calcitriol, and androgen (2006 · Leukemia Research · 被引 7)
• Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients (2016 · Leukemia Research · 被引 6)
• The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma (2025 · Blood · 被引 4)
• [Small interfering RNA targeting C-erbB-2 gene increases the radiosensitivity of lung adenocarcinoma cells in vitro]. (2008 · PubMed · 被引 1)